Progyny Inc (PGNY)
33.10
+0.05 (+0.15%)
USD |
NASDAQ |
Mar 24, 16:00
33.08
-0.02 (-0.06%)
After-Hours: 20:00
Progyny Revenue (Annual): 786.91M for Dec. 31, 2022
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2022 | 786.91M |
December 31, 2021 | 500.62M |
December 31, 2020 | 344.86M |
Date | Value |
---|---|
December 31, 2019 | 229.68M |
December 31, 2018 | 105.40M |
December 31, 2017 | 48.58M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
105.40M
Minimum
2018
786.91M
Maximum
2022
393.50M
Average
344.86M
Median
2020
Revenue (Annual) Benchmarks
Fulgent Genetics Inc | 618.97M |
Delcath Systems Inc | 3.555M |
CytoSorbents Corp | 29.36M |
Star Equity Holdings Inc | 112.15M |
Exact Sciences Corp | 2.084B |